Maryse Laliberte

Title: Maryse Laliberte: Innovator in Enzyme Production

Introduction

Maryse Laliberte is a notable inventor based in Boisbriand, Canada. She has made significant contributions to the field of biochemistry, particularly in the production of chondroitin lyase enzymes. With a total of 2 patents, her work has implications for various applications in medical and biochemical research.

Latest Patents

Laliberte's latest patents focus on the production of highly purified enzymes capable of degrading chondroitin sulfate polysaccharides. The invention outlines a multi-step purification method that includes cell disruption, cation exchange chromatography, affinity chromatography, hydroxylapatite chromatography, high-resolution ion exchange chromatography, and size exclusion. Two specific proteins were isolated: a 77,000 ± 5,000 Dalton protein that degrades chondroitin sulfates A and C, and a 55,000 ± 2,300 Dalton protein that degrades dermatan sulfate. The genes encoding these enzymes, chondroitinase AC and chondroitinase B, have been cloned, and methods for their use are also described.

Career Highlights

Maryse Laliberte is currently employed at Ibex Technologies R and D, Inc., where she continues her innovative work in enzyme production. Her research has contributed to advancements in the understanding and application of chondroitin lyase enzymes.

Collaborations

Some of her notable coworkers include D Clark Bennett and Kangfu Gu, who have collaborated with her on various projects related to enzyme research.

Conclusion

Maryse Laliberte's contributions to the field of enzyme production highlight her role as an influential inventor. Her work not only advances scientific knowledge but also opens new avenues for research and application in biochemistry.